– JERSEY, St Helier – Centamin PLC (LSE:CEY | TSX:CEE) today announced the appointment of Dr. Sally Eyre, B.Sc., Ph.D., DIC, as an independent Non-Executive Director, effective 10 April 2019.
Following Dr. Eyre’s appointment, the Centamin Board will comprise of nine members: the non-executive Chair, two Executives and six independent Non-Executives. This appointment is in accordance with the UK Corporate Governance Code and the Company’s ongoing commitment to achieving the highest standards of corporate governance.
Josef El-Raghy, Chairman commented: “We are delighted to be welcoming Sally to the Company. Her excellent technical skills and experience acquired throughout her career will be a valued addition to our existing diverse and multidisciplinary Board.”
About Dr Sally Eyre
Dr. Eyre is a mining finance professional with extensive experience in global resource capital markets and mining operations. As a geologist, obtaining her doctoral degree in Economic Geology from the Royal School of Mines, Imperial College, London, Dr. Eyre brings strong technical balance to the existing Board composition.
Throughout Dr. Eyre’s career, she has acquired substantial capital market, finance and directorate expertise. From 2011 to 2014, Dr. Eyre was President and Chief Executive Officer of TSX Venture Exchange listed Copper North Mining. Prior to this, from 2008 to 2011, she was an executive with Endeavour Financial, which transformed into the intermediate gold mining Company, Endeavour Mining. During this period of transformation, Dr. Eyre served as the President and Chief Executive Officer of Etruscan Resources and subsequently as Senior Vice President Operations, of Endeavour Mining.
Dr. Eyre currently holds two non-executive directorships: Adventus Zinc Corporation and Japan Gold Corporation. Adventus Zinc is a TSX Venture Exchange listed company. Dr. Eyre has been a Non-Executive Director since 2017, where she is the Chair of the Corporate Governance Committee and a member of the Audit Committee and Steering Committee. Japan Gold is a TSX Venture Exchange listed company. Dr. Eyre has been a Non-Executive Director since 2016, where she is the Chair of the Corporate Governance Committee and a member of the Audit Committee.
For more information : http://www.centamin.com
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.
August 15, 2019